Tumor-specific usage of alternative transcription start sites in colorectal cancer identified by genome-wide exon array analysis

Background Approximately half of all human genes use alternative transcription start sites (TSSs) to control mRNA levels and broaden the transcriptional output in healthy tissues. Aberrant expression patterns promoting carcinogenesis, however, may arise from alternative promoter usage.